Delivery Order SPE2DB22D3004-SPE2DB24FQV99

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,061.44 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,263.19 firm fixed price delivery order was awarded on May 28, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a performance period ending on May 29, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $1,687.98 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 28, 2025, with a completion date of April 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,210.73, was awarded on July 12, 2024 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract has a firm fixed-price pricing type and an ultimate completion date of July 15, 2024....
This federal contract award is for the delivery of fluticasone-salmeterol 45-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,035.88 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2025, with a completion date of January 27, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Fluticasone-Salmeterol 115-21 12GM medical products to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $3,118.10, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,981.33 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024, with a completion date of December 10, 2024. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp maintains a $999,999,999 Indefinite...
This federal contract award is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,237.14 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 19, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
The federal contract award is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency, with a ceiling value of $1,551.02. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 10, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This contract is not set-aside...
This contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products. The contract has a ceiling value of $21,794.84 and runs through February 6, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQV99
    Delivery Order

This contract award is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,613.31, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 25, 2024. The contract is a delivery order with a firm fixed price.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/24/24, 9:11 AM